XML 126 R45.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION AND OTHER BENEFIT PLANS (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]  
Schedule of Stock-Based Compensation
Year Ended December 31,
202420232022
(in thousands)
Stock-based compensation - equity awards$4,567 $3,338 $2,045 
Stock-based compensation - liability awards(9)(15)155 
Total stock-based compensation$4,558 $3,323 $2,200 
Schedule of Weighted Average Grant Date Fair Value of Performance Stock Options Grants
During the year ended December 31, 2024, 2023 and 2022 the weighted average assumptions shown below were used to calculate the weighted average grant date fair value of performance stock options grants under the Monte Carlo model.
Year Ended December 31,
202420232022
Weighted average exercise price - ($/share)$5.96 $4.19 $6.41 
Expected life in years6.76.46.0
Average expected volatility71 %68 %72 %
Risk-free interest rate4.28 %3.73 %1.98 %
Expected dividend yield4.19 %5.97 %2.30 %
Weighted average grant date fair value - ($/share)$3.27 $2.29 $2.84 
Schedule of Performance Stock Options Activity
Performance stock options activity associated with the Monte Carlo model for the year ended December 31, 2024 is provided below:
Number of Shares Underlying OptionsWeighted Average Exercise Price Per
Share
Weighted Average Remaining
Contractual Term
Aggregate Intrinsic Value
(in thousands)  (in years)(in thousands)
Outstanding at January 1, 2024611$4.69 
Granted5495.96 
Exercised(24)4.54 
Unvested shares forfeited(18)4.19 
Vested shares expired— 
Outstanding at December 31, 20241,118$5.32 8.6$185 
Exercisable at December 31, 2024228$4.22 7.4$147 
Regular stock options (stock options without a performance condition) activity associated with the Black-Scholes model for the year ended December 31, 2024 is provided below:
Number of Shares Underlying Options
Weighted Average Exercise Price Per Share
(in thousands)
Outstanding at January 1, 2024170$1.99 
Exercised(170)1.99 
Outstanding at December 31, 2024$— 
Schedule of Restricted Stock Activity
The following is the activity for the Company's restricted stock for the year ended December 31, 2024:
Restricted StockWeighted Average Grant Date Fair Value
(in thousands)
Non-vested shares outstanding at January 1, 20241,085$4.50 
Awards granted8385.96 
Awards vested(508)4.42 
Awards forfeited(63)5.14 
Non-vested shares outstanding at December 31, 20241,352$5.41 
RSU activity for the year ended December 31, 2024 is presented in the table below:
Restricted StockWeighted Average Conversion Date Fair Value
(in thousands)
Non-vested shares outstanding at January 1, 2024223$4.22 
Awards granted805.96 
Awards vested(102)4.23 
Awards forfeited(27)4.20 
Non-vested shares outstanding at December 31, 2024174$5.01 
Schedule of Performance Activity
PSU activity for the year ended December 31, 2024 is presented in the table below:
Restricted StockWeighted Average Conversion Date Fair Value
(in thousands)
Non-vested shares outstanding at January 1, 2024121$4.27 
Awards granted— 
Awards vested(103)4.27 
Awards forfeited(9)4.27 
Non-vested shares outstanding at December 31, 20249$4.27 
Schedule of SAR Activity
During the years ended December 31, 2024 and 2023, the Company did not grant SARs to employees or directors. SAR activity for the year ended December 31, 2024 is provided below:
Number of Shares Underlying SARsWeighted Average Exercise Price Per
Share
(in thousands) 
Outstanding at January 1, 202476$2.33 
Exercised(76)2.33 
Outstanding at December 31, 2024